Ramin Salehi-Rad

6PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 25, 2026
FLT3L-secreting cDC1 in situ vaccination enhances antitumor immunity and synergizes with PD-1 blockade in murine non-small cell lung cancer.

|Nov 19, 2024
Characteristics of a CCL21 Gene-Modified Dendritic Cell Vaccine Utilized for a Clinical Trial in Non-Small Cell Lung Cancer.

Michael S Oh, Camelia Dumitras, Ramin Salehi-Rad

|Sep 26, 2024
Hyper-Interferon Sensitive Influenza Induces Adaptive Immune Responses and Overcomes Resistance to Anti-PD-1 in Murine Non-Small Cell Lung Cancer.

Yushen Du, Ramin Salehi-Rad, Tian-Hao Zhang

|Sep 20, 2023
CCL21-DC in situ vaccination in murine NSCLC overcomes resistance to immunotherapy and generates systemic tumor-specific immunity.

Ramin Salehi-Rad, Raymond J Lim, Yushen Du

|Jul 21, 2023
Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma.

Jane Yanagawa, Linh M Tran, Ramin Salehi-Rad

|Jan 28, 2021
Novel Kras-mutant murine models of non-small cell lung cancer possessing co-occurring oncogenic mutations and increased tumor mutational burden.

Ramin Salehi-Rad, Rui Li, Linh M Tran

Pageof 1

Frequent Collaborators

4 joint publications

Bin Liu

3 joint publications

Steven M Dubinett

2 joint publications

Linh M Tran

2 joint publications

Raymond J Lim